This report provides an update on the present state of coverage, availability of, and access to, medications for treating ongoing alcohol use disorder and opioid use disorder, and reversing an opioid overdose within state Medicaid plans.
This report, produced in collaboration with the Partnership to End Addiction, analyzes states' parity compliance reporting requirements for mental health and substance use disorder,
This report, produced in collaboration with the Partnership to End Addiction, discusses federal and state regulation and enforcement of the Parity Act with regard to network adequacy for substance use disorder and mental health services.
This report, produced in collaboration with the Partnership to End Addiction, analyzes requirements for health plans to use specific criteria and assessment tools to determine medical necessity for substance use disorders.
This web page is a resource center for social media, video, print, radio, FAQs, messaging, and other marketing materials that can be used to promote the 988 Suicide & Crisis Lifeline. It is designed for states, territories, tribes, crisis centers, communities, emergency service providers, and other partners to speak with one voice.
This public meeting explored real-world experiences and scientific evidence on emerging data trends for human xylazine exposure and examined concrete strategies for drug development and clinical research.
This issue brief provides federal and state policymakers with ways they can support low-threshold buprenorphine prescribing through reimbursement policies, treatment guidelines, and regulations.
This report, produced in collaboration with the Partnership to End Addiction, analyzes standards of prior authorization requirements in both public and private insurance plans.
These recommendations from TFAH, primarily aimed at federal and state governments, aim to reduce alcohol, drug, and suicide deaths and to improve mental health and well-being for all Americans.
This chartbook examines opioid treatment program regulations across all 50 states and the District of Columbia as of June 2021 in terms of access to care and patient experience.